MDT241108C92000
- 0.05
- -0.07-58.33%
Medtronic Newsroom
Wells Fargo Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $106
BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $100
BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $100
Medtronic Analyst Ratings
BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $100
Needham Maintains Medtronic(MDT.US) With Hold Rating
BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $100
Medtronic (MDT) Gets a Hold From Stifel Nicolaus
Baird Maintains Medtronic(MDT.US) With Hold Rating, Raises Target Price to $96
Truist Financial Maintains Medtronic(MDT.US) With Hold Rating, Raises Target Price to $93
Medtronic Analyst Ratings
Truist Raises Price Target on Medtronic to $93 From $90, Maintains Hold Rating
Morgan Stanley Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $98
Buy Rating on Medtronic: Stable Demand, Margin Improvement, and Strategic Positioning Fuel Optimistic Outlook
RBC Capital Upgrades Medtronic(MDT.US) to Buy Rating, Raises Target Price to $105
Medtronic Is Maintained at Sector Perform by RBC Capital
Medtronic Analyst Ratings
RBC Capital Maintains Medtronic(MDT.US) With Hold Rating, Raises Target Price to $98
Bernstein Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $96
Bernstein Sticks to Its Buy Rating for Medtronic (MDT)